Results 231 to 240 of about 1,046,192 (353)
New strategies for polymer development in pharmaceutical science — a short review [PDF]
Antony Godwin +6 more
openalex +1 more source
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg +20 more
wiley +1 more source
Application of magnetic nanoparticles in pharmaceutical sciences. [PDF]
Marszałł MP.
europepmc +1 more source
Objective Body mass index (BMI), glomerular filtration rate (GFR), and pretreatment urate levels have been reported to influence the urate‐lowering response to allopurinol. We investigated whether the fractional excretion of uric acid (FEUA) also modulates this response and relates to oxypurinol concentrations.
Pascal Richette +13 more
wiley +1 more source
Bridging theory and practice: Mixed methods approach to instruction of law and ethics within the pharmaceutical sciences. [PDF]
Wilby KJ, Nasr ZG.
europepmc +1 more source
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner +14 more
wiley +1 more source
Remington's pharmaceutical sciences
openaire +3 more sources
The 9th International Conference on Biomedical Engineering and Pharmaceutical Sciences (ICBEPS2024). [PDF]
europepmc +1 more source
Core competencies for research training in the clinical pharmaceutical sciences. [PDF]
Poloyac SM +9 more
europepmc +1 more source
Addressing Economic Insecurities Can Improve Patient‐Reported Outcomes in Lupus
Background Economic insecurities, such as food, housing, transportation, and financial challenges, are modifiable risk factors and influence patient‐reported outcomes (PROs) in systemic lupus erythematosus (SLE). We examined: 1) associations between economic insecurities and PROs; 2) the impact of screening and addressing economic insecurities during ...
Jay Patel +8 more
wiley +1 more source

